ReviewCancer management and research2022

Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to Date.

Sunil Girish Iyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.